![PDF] Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/64d620321dfe4fcc85537c0e0a6f9260a019b8fa/2-Figure1-1.png "PDF] Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics | Semantic Scholar")
PDF] Pharmacology of new oral anticoagulants: mechanism of action, pharmacokinetics, pharmacodynamics | Semantic Scholar
Use of idarucizumab in reversing dabigatran anticoagulant effect: a cr | TCRM
Mechanism of action of dabigatran, rivaroxaban and warfarin. | Download Scientific Diagram
Idarucizumab, a Specific Reversal Agent for Dabigatran: Mode of Action, Pharmacokinetics and Pharmacodynamics, and Safety and Efficacy in Phase 1 Subjects - The American Journal of Medicine
The mechanism of action of rivaroxaban – an oral, direct Factor Xa inhibitor – compared with other anticoagulants - Thrombosis Research
Dabigatran (Pradaxa) | American Journal of Neuroradiology
Direct-acting Oral Anticoagulants in Dermatologic Surgery | Actas Dermo-Sifiliográficas
New oral anticoagulant drugs – mechanisms of action | Earl's View
Dentistry Journal | Free Full-Text | New Direct Oral Anticoagulants (DOAC) and Their Use Today | HTML
Christopher Malabanan, Pharm.D., BCPS, CACP Jenny Park, Pharm.D. - ppt download
New Oral Anticoagulants in Atrial Fibrillation and Acute Coronary Syndromes: ESC Working Group on Thrombosis—Task Force on Anticoagulants in Heart Disease Position Paper - ScienceDirect
Dabigatran: review of pharmacology and management of bleeding complications of this novel oral anticoagulant. - Abstract - Europe PMC
New Anticoagulants – 5 Deaths Prompt Dabigatran Safety Advisory in Japan | Earl's View
Dabigatran: Review of Pharmacology and Management of Bleeding Complications of This Novel Oral Anticoagulant | SpringerLink
Medicines | Free Full-Text | Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update | HTML
The use of dabigatran in general practice - BPJ Issue 38
Nutrients | Free Full-Text | New Insights into the Pros and Cons of the Clinical Use of Vitamin K Antagonists (VKAs) Versus Direct Oral Anticoagulants (DOACs) | HTML
Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease | American Society of Nephrology
Mechanism of action of warfarin, dabigatran, rivaroxaban, and apixaban... | Download Scientific Diagram
PRADAXA (DABAGATRAN), A New Anticoagulant for Stroke and Embolism Prevention
Anticoagulant - Wikipedia
Mechanism of action of the non-vitamin K antagonist oral anticoagulants... | Download Scientific Diagram
Dabigatran Etexilate | Circulation
Summary of Pradaxa (dabigatran) key information
